Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma

References

• UstundagYBayraktarYCholangiocarcinoma: a compact review of the literatureWorld J Gastroenterol2008146458646619030196
   PubMed Web of Science ®Google Scholar
• KhanSAThomasHCDavidsonBRTaylor-RobinsonSDCholangiocarcinomaLancet20053661303131416214602
   PubMed Web of Science ®Google Scholar
• PatelTIncreasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United StatesHepatology2001331353135711391522
   PubMed Web of Science ®Google Scholar
• ShaibYEl-SeragHBThe epidemiology of cholangiocarcinomaSemin Liver Dis20042411512515192785
   PubMed Web of Science ®Google Scholar
• Liver Cancer Study Group of JapanClassification of Primary Liver CancerFirst English editionTokyoKanehara Press Co1997
   Google Scholar
• WeberSMJarnaginWRKlimstraDDeMatteoRPFongYBlumgartLHIntrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomesJ Am Coll Surg200119338439111584966
   PubMed Web of Science ®Google Scholar
• RazumilavaNGoresGJCholangiocarcinomaLancet201438399352168217924581682
   PubMed Web of Science ®Google Scholar
• UenishiTHirohashiKKuboSHistologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinomaWorld J Surg20012586586911572025
   PubMed Web of Science ®Google Scholar
• JarnaginWRFongYDeMatteoRPStaging, resectability, and outcome in 225 patients with hilar cholangiocarcinomaAnn Surg200123450751911573044
   PubMed Web of Science ®Google Scholar
• de GroenPCGoresGJLaRussoNFBiliary tract cancersN Engl J Med19993411368137810536130
   PubMed Web of Science ®Google Scholar
• ShirabeKShimadaMHarimotoNIntrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalitiesSurgery2002131S159S16411821804
   PubMed Web of Science ®Google Scholar
• BatheOFPachecoJTOssiPBManagement of hilar bile duct carcinomaHepatogastroenterology2001481289129411677948
   PubMedGoogle Scholar
• UtispanKThuwajitPAbikoYGene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic markerMol Cancer2010913
   PubMed Web of Science ®Google Scholar
• SeolMAChuISLeeMJGenome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinomaBMC Cancer2011117821333016
   PubMed Web of Science ®Google Scholar
• FunkSESageEHThe Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cellsProc Natl Acad Sci U S A19918826482652
   PubMed Web of Science ®Google Scholar
• KalluriRZeisbergMFibroblasts in cancerNat Rev Cancer2006639240116572188
   PubMed Web of Science ®Google Scholar
• PuolakkainenPABrekkenRAMuneerSSageEHEnhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosisMol Cancer Res2004221522415140943
   PubMed Web of Science ®Google Scholar
• BrekkenRAPuolakkainenPGravesDCWorkmanGLubkinSRSageEHEnhanced growth of tumors in SPARC null mice is associated with changes in the ECMJ Clin Invest200311148749512588887
   PubMed Web of Science ®Google Scholar
• SatoNFukushimaNMaeharaNSPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactionsOncogene20032250215030
   PubMed Web of Science ®Google Scholar
• YamashitaKUpadhaySMimoriKInoueHMoriMClinical significance of secreted protein acidic and rich in cysteine in esophageal carcinoma and its relation to carcinoma progressionCancer20039724122419
   PubMed Web of Science ®Google Scholar
• WatkinsGDouglas-JonesABryceRManselREJiangWGIncreased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomesProstaglandins Leukot Essent Fatty Acids20057226727215763438
   PubMed Web of Science ®Google Scholar
• PiaoCQLiuLZhaoYLBalajeeASSuzukiMHeiTKImmortalization of human small airway epithelial cells by ectopic expression of telomeraseCarcinogenesis20052672573115677631
   PubMed Web of Science ®Google Scholar
• YamanakaMKandaKLiNCAnalysis of the gene expression of SPARC and its prognostic value for bladder cancerJ Urol20011662495249911696817
   PubMed Web of Science ®Google Scholar
• UeharaHNakaizumiATatsutaMDiagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutationsAm J Gastroenterol1999942513251810484017
   PubMed Web of Science ®Google Scholar
• JacobKWebberMBenayahuDKleinmanHKOsteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to boneCancer Res1999594453445710485497
   PubMed Web of Science ®Google Scholar
• BriggsJChamboredonSCastellazziMKerryJABosTJTranscriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cellsOncogene2002217077709112370830
   PubMed Web of Science ®Google Scholar
• HandrichSJHoughDMFletcherJGSarrMGThe natural history of the incidentally discovered small simple pancreatic cyst: long-term follow-up and clinical implicationsAJR Am J Roentgenol2005184202315615944
   PubMed Web of Science ®Google Scholar
• WangCSLinKHChenSLChanYFHsuehSOverexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significanceBr J Cancer2004911924193015558074
   PubMed Web of Science ®Google Scholar
• InfanteJRMatsubayashiHSatoNPeritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinomaJ Clin Oncol200725331932517235047
   PubMed Web of Science ®Google Scholar
• MantoniTSSchendelRRRödelFStromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinomaCancer Biol Ther20087111806181518787407
   PubMed Web of Science ®Google Scholar
• OhtsukaMItoHKimuraFResults of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survivalBr J Surg200289121525153112445060
   PubMed Web of Science ®Google Scholar
• ChenMFTsaiHPJengLBPrognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysisWorld J Surg200327444344712658490
   PubMed Web of Science ®Google Scholar
• YehCNChenMFLeeWCJengLBPrognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysisJ Surg Oncol200281419520212451624
   PubMed Web of Science ®Google Scholar
• YehCNLeeWCChenMFHepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospitalAnn Surg Oncol20031091070107614597446
   PubMed Web of Science ®Google Scholar
• KlompjeJPetrelliNJHerreraLMittelmanAThe prognostic value of preoperative alkaline phosphatase for resection of solitary liver metastasis from colorectal carcinomaEur J Surg Oncol19871343453473622787
   PubMed Web of Science ®Google Scholar
• ChuKTeeleNDeweyMWAlbrightNDeweyWCComputerized video time lapse study of cell cycle delay and arrest, mitotic catastrophe, apoptosis and clonogenic survival in irradiated 14-3-3sigma and CDKN1A (p21) knockout cell linesRadiat Res200416227028615332997
   PubMed Web of Science ®Google Scholar
• OkabayashiTYamamotoJKosugeTThe utility of CA19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitisAm J Gastroenterol20009520420710638584
   PubMed Web of Science ®Google Scholar
• ChenMFPeripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatmentJ Gastroenterol Hepatol1999141144114910634149
   PubMed Web of Science ®Google Scholar
• YehCNJanYYYehTSHwangTLChenMFHepatic resection of intraductal papillary type of cholangiocarcinomaAnn Surg Oncol20041160661115172934
   PubMed Web of Science ®Google Scholar
• LevyMJSmyrkTCReddyRPEndoscopic ultrasound-guided trucut biopsy of the cyst wall for diagnosing cystic pancreatic tumorsClin Gastroenterol Hepatol2005397497916234042
   PubMed Web of Science ®Google Scholar
• WestRBNuytenDSSubramanianSDetermination of stromal signatures in breast carcinomaPLoS Biol20053e18715869330
   PubMed Web of Science ®Google Scholar
• KoukourakisMIGiatromanolakiABrekkenRAEnhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patientsCancer Res2003635376538014500371
   PubMed Web of Science ®Google Scholar
• JonesCMackayAGrigoriadisAExpression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancerCancer Res2004643037304515126339
   PubMed Web of Science ®Google Scholar
• LindmarkFZhengSLWiklundFH6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancerJ Natl Cancer Inst2004961248125415316060
   PubMed Web of Science ®Google Scholar
• HuMYaoJCaiLDistinct epigenetic changes in the stromal cells of breast cancersNat Genet20053789990516007089
   PubMed Web of Science ®Google Scholar
• WatkinsGMartinTABryceRManselREJiangWGGamma-linolenic acid regulates the expression and secretion of SPARC in human cancer cellsProstaglandins Leukot Essent Fatty Acids20057227327815763439
   PubMed Web of Science ®Google Scholar
• TaiITDaiMOwenDAChenLBGenome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapyJ Clin Invest20051151492150215902309
   PubMed Web of Science ®Google Scholar
• JohnTAVogelSMTiruppathiCMalikABMinshallRDQuantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayerAm J Physiol Lung Cell Mol Physiol2003284L187L19612471015
   PubMed Web of Science ®Google Scholar
• MinshallRDSessaWCStanRVCaveolin regulation of endothelial functionAm J Physiol Lung Cell Mol Physiol2003285L1179L118314604847
   PubMed Web of Science ®Google Scholar
• SchnitzerJEOhPAntibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endotheliumAm J Physiol Heart Circ Physiol1992263H1872H1879
   Web of Science ®Google Scholar
• TiruppathiCFinneganAMalikABIsolation and characterization of a cell surface albuminbinding protein from vascular endothelial cellsProc Natl Acad Sci U S A1996932502548552615
   PubMed Web of Science ®Google Scholar
• MotzerRJMichaelsonMDRedmanBGActivity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinomaJ Clin Oncol200624162416330672
   PubMed Web of Science ®Google Scholar
• HurwitzHFehrenbacherLNovotnyWBevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerN Engl J Med20043502335234215175435
   PubMed Web of Science ®Google Scholar
• FaivreLGuardiolaPLewisCAssociation of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research GroupBlood2000964064407011110674
   PubMed Web of Science ®Google Scholar